Related references
Note: Only part of the references are listed.Molecular evolution of the proopiomelanocortin system in Barn owl species
Karin Loew et al.
PLOS ONE (2020)
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Jolene L. Lau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Recent updates on GLP-1 agonists: Current advancements & challenges
Dilip Sharma et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides
Alessandro Zorzi et al.
NATURE COMMUNICATIONS (2017)
ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?
Davids Fridmanis et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment
Thomas C. Marbury et al.
CLINICAL PHARMACOKINETICS (2017)
The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling
Rachel L. Dods et al.
BIOSCIENCE REPORTS (2016)
Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials
Jeanne S. Geiser et al.
CLINICAL PHARMACOKINETICS (2016)
The proopiomelanocortin gene: discovery, deletion and disease
Adrian J. L. Clark
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Half-life extended biotherapeutics
Roland E. Kontermann
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
A biomimetic approach for enhancing the in vivo half-life of peptides
Sravan C. Penchala et al.
NATURE CHEMICAL BIOLOGY (2015)
MC1R, Eumelanin and Pheomelanin: Their Role in Determining the Susceptibility to Skin Cancer
Tahseen H. Nasti et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2015)
Melanocortin/melanocortin receptors
Robert M. Dores et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Synaptic changes induced by melanocortin signalling
Vanni Caruso et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Neurotensin and neurotensin receptors: Characteristic, structure-activity relationship and pain modulation-A review
Patrycja Kleczkowska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Diverse Roles of Neurotensin Agonists in the Central Nervous System
Mona Boules et al.
Frontiers in Endocrinology (2013)
The structure and function of the glucagon-like peptide-1 receptor and its ligands
Dan Donnelly
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice
Ko-Eun Choi et al.
FASEB JOURNAL (2012)
Association between melanism, physiology and behaviour: A role for the melanocortin system
Alexandre Roulin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Design and In vitro Evaluation of Branched Peptide Conjugates: Turning Nonspecific Cytotoxic Drugs into Tumor-Selective Agents
Chiara Falciani et al.
CHEMMEDCHEM (2010)
Synthetic therapeutic peptides: science and market
Patrick Vlieghe et al.
DRUG DISCOVERY TODAY (2010)
A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In vitro and In vivo
Kuzhuvelil B. Harikumar et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Suppression of Neurotensin Receptor Type 1 Expression and Function by Histone Deacetylase Inhibitors in Human Colorectal Cancers
Xiaofu Wang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The Melanocortin System in Control of Inflammation
Anna Catania et al.
THESCIENTIFICWORLDJOURNAL (2010)
Adrenocorticotropic Hormone, Melanocyte-stimulating Hormone, and the Melanocortin Receptors: Revisiting the Work of Robert Schwyzer A Thirty-Year Retrospective
Robert M. Dores
TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY (2009)
Engineered luciferases for molecular sensing in living cells
Brock Binkowski et al.
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Lys-gamma3-MSH: A global regulator of hormone sensitive lipase activity?
Katrina A. Bicknell et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes
Jessica E. Matthews et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Evidence of a possible role for Lys-gamma 3-MSH in the regulation of adipocyte function
Stephen C. Harmer et al.
JOURNAL OF ENDOCRINOLOGY (2008)
MC1R:: three novel variants identified in a malignant melanoma association study in the Spanish population
L. P. Fernandez et al.
CARCINOGENESIS (2007)
Studies on the physiological functions of the melanocortin system
Roger D. Cone
ENDOCRINE REVIEWS (2006)
Bioactive analogs of neurotensin: Focus on CNS effects
Mona Boules et al.
PEPTIDES (2006)
Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation
Dezheng Zhao et al.
PEPTIDES (2006)
Differential processing of pro-neurotensin/neuromedin N and relationship to pro-hormone convertases
Patrick Kitabgi
PEPTIDES (2006)
The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R)
DL Marks et al.
PEPTIDES (2006)
Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk
KA Beaumont et al.
HUMAN MOLECULAR GENETICS (2005)
Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation
P Brun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus
OG Kolterman et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2005)
No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis
FK Knop et al.
DIABETES CARE (2003)
Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects
T Vilsboll et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Neurotensin: an endogenous antipsychotic? Commentary
B Kinkead et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration
S Mock et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2002)
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
MA Cowley et al.
NATURE (2001)
No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose
T Vilsboll et al.
DIABETIC MEDICINE (2001)
Neurotensin: peptide for the next millennium
BM Tyler-McMahon et al.
REGULATORY PEPTIDES (2000)
Investigation of the melanocyte stimulating hormones on food intake - Lack of evidence to support a role for the melanocortin-3-receptor
CR Abbott et al.
BRAIN RESEARCH (2000)
Highly potent neurotensin analog that causes hypothermia and antinociception
BM Tyler-McMahon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
